Current GST Rate Structure for Healthcare in India
| Healthcare Item / Service | GST Rate | Notes |
|---|---|---|
| Healthcare services by hospitals & doctors | Nil (Exempt) | Clinical establishment services are exempt |
| Generic medicines (non-branded) | Nil | Specified medicines exempt |
| Life-saving drugs (listed) | 5% | Specific drugs notified by government |
| Most medicines & pharmaceuticals | 12% | Bulk of pharma sector |
| Ayurvedic, homeopathic medicines | 12% | Branded products |
| Medical devices & equipment | 12% / 18% | Varies by device type |
| Diagnostic services | Nil (Exempt) | Clinical lab tests exempt |
| Health insurance premiums | 18% (was) | Senior citizens: Now Nil |
| Ambulance services | Nil | Exempt |
| COVID vaccines (when available) | 5% | Concessional rate |
GST 2.0 Changes in Healthcare Rates
1. Health Insurance — Major Relief in June 2025
The most significant healthcare GST change in GST 2.0: Following the 56th GST Council meeting (June 2025), GST on individual term life insurance premiums was reduced to Nil from 18%, and health insurance for senior citizens (60+) was also fully exempted from GST.
For other health insurance policyholders, GST remains at 18% currently, but there is pressure to reduce this further.
2. Cancer Drugs — Rate Reduction
In August 2024, GST on specific cancer drugs — including Trastuzumab, Osimertinib, and Durvalumab — was reduced from 12% to 5%. This followed recommendations from the 54th GST Council meeting, providing significant relief to cancer patients.
3. Medical Devices — Rationalisation Underway
Several medical devices currently at 18% GST are under consideration for reduction to 12% or 5%. The GoM report has flagged inverted duty structure issues in medical devices where raw materials face higher GST than finished devices.
4. Generic Medicines — Status Quo with Clarifications
Nil-rated generic medicines (unbranded) continue to be exempt. However, clarifications have been issued to distinguish between branded and unbranded medicines for GST purposes, resolving long-standing classification disputes.
Impact on Pharmacy Businesses
For pharmacy businesses managing multiple GST rates, here is what GST 2.0 means in practice:
- Bifurcation required: Pharmacies must accurately classify each medicine/device into the correct GST slab (Nil, 5%, 12%, 18%)
- ITC management: Rate changes on specific drugs affect ITC calculations and reconciliation
- Billing software: Must support automatic HSN-to-rate mapping with frequent updates
- GSTR reporting: Multiple rate categories require careful GSTR-1 and GSTR-3B preparation
Milaan ERP for Pharma GST
Milaan ERP's pharmacy module handles multi-rate GST billing seamlessly — automatically applying the correct tax rate to each medicine based on HSN code, keeping your pharmacy 100% GST compliant.
What the 18% vs 5% GST Debate Means for Patients
The debate over 5% vs 18% GST in healthcare has direct impact on patient costs:
| Scenario | GST Rate | Impact on Patient |
|---|---|---|
| Health insurance premium ₹20,000/year | 18% → savings on senior citizen premiums | ₹3,600 annual savings for senior citizens |
| Cancer drug costing ₹50,000/month | 12% → 5% | ₹3,500/month saving on cancer treatment |
| Medical device purchase ₹1,00,000 | If reduced from 18% to 12% | ₹6,000 saving |
Complete Pharma GST Solution — Milaan ERP
From multi-rate GST billing to expiry management and GSTR-3B auto-reports — Milaan ERP's pharmacy module handles all GST 2.0 healthcare rate changes automatically. Trusted by 5,000+ pharmacies across India.
FAQs on GST Healthcare Rates
Perfect GST Compliance for Your Pharmacy
Milaan ERP handles multi-rate GST, medicine HSN codes, expiry tracking, and GSTR auto-reports — designed specifically for Indian pharmacies.